Mutations of the RET-GDNF signaling pathway in Ondine's curse - PubMed (original) (raw)
- PMID: 9497256
- PMCID: PMC1376953
- DOI: 10.1086/301759
Mutations of the RET-GDNF signaling pathway in Ondine's curse
J Amiel et al. Am J Hum Genet. 1998 Mar.
No abstract available
Similar articles
- The GDNF-RET signalling partnership.
Robertson K, Mason I. Robertson K, et al. Trends Genet. 1997 Jan;13(1):1-3. doi: 10.1016/s0168-9525(96)30113-3. Trends Genet. 1997. PMID: 9009838 Review. No abstract available. - Expression of RET and its ligand complexes, GDNF/GFRalpha-1 and NTN/GFRalpha-2, in medullary thyroid carcinomas.
Frisk T, Farnebo F, Zedenius J, Grimelius L, Höög A, Wallin G, Larsson C. Frisk T, et al. Eur J Endocrinol. 2000 Jun;142(6):643-9. doi: 10.1530/eje.0.1420643. Eur J Endocrinol. 2000. PMID: 10822229 - Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.
Carlomagno F, Melillo RM, Visconti R, Salvatore G, De Vita G, Lupoli G, Yu Y, Jing S, Vecchio G, Fusco A, Santoro M. Carlomagno F, et al. Endocrinology. 1998 Aug;139(8):3613-9. doi: 10.1210/endo.139.8.6124. Endocrinology. 1998. PMID: 9681515 - Evidence for a ligand-specific signaling through GFRalpha-1, but not GFRalpha-2, in the absence of Ret.
Pezeshki G, Franke B, Engele J. Pezeshki G, et al. J Neurosci Res. 2001 Nov 1;66(3):390-5. doi: 10.1002/jnr.1231. J Neurosci Res. 2001. PMID: 11746356 - GDNF family neurotrophic factor signaling: four masters, one servant?
Airaksinen MS, Titievsky A, Saarma M. Airaksinen MS, et al. Mol Cell Neurosci. 1999 May;13(5):313-25. doi: 10.1006/mcne.1999.0754. Mol Cell Neurosci. 1999. PMID: 10356294 Review. No abstract available.
Cited by
- Genetic Factors Underlying Sudden Infant Death Syndrome.
Keywan C, Poduri AH, Goldstein RD, Holm IA. Keywan C, et al. Appl Clin Genet. 2021 Feb 15;14:61-76. doi: 10.2147/TACG.S239478. eCollection 2021. Appl Clin Genet. 2021. PMID: 33623412 Free PMC article. Review. - Research Advances on Therapeutic Approaches to Congenital Central Hypoventilation Syndrome (CCHS).
Di Lascio S, Benfante R, Cardani S, Fornasari D. Di Lascio S, et al. Front Neurosci. 2021 Jan 12;14:615666. doi: 10.3389/fnins.2020.615666. eCollection 2020. Front Neurosci. 2021. PMID: 33510615 Free PMC article. Review. - Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.
Drilon A, Hu ZI, Lai GGY, Tan DSW. Drilon A, et al. Nat Rev Clin Oncol. 2018 Mar;15(3):151-167. doi: 10.1038/nrclinonc.2017.175. Epub 2017 Nov 14. Nat Rev Clin Oncol. 2018. PMID: 29134959 Free PMC article. Review. - Congenital central hypoventilation syndrome: a bedside-to-bench success story for advancing early diagnosis and treatment and improved survival and quality of life.
Weese-Mayer DE, Rand CM, Zhou A, Carroll MS, Hunt CE. Weese-Mayer DE, et al. Pediatr Res. 2017 Jan;81(1-2):192-201. doi: 10.1038/pr.2016.196. Epub 2016 Sep 27. Pediatr Res. 2017. PMID: 27673423 Review. - PHOX2B polyalanine repeat length is associated with sudden infant death syndrome and unclassified sudden infant death in the Dutch population.
Liebrechts-Akkerman G, Liu F, Lao O, Ooms AH, van Duijn K, Vermeulen M, Jaddoe VW, Hofman A, Engelberts AC, Kayser M. Liebrechts-Akkerman G, et al. Int J Legal Med. 2014 Jul;128(4):621-9. doi: 10.1007/s00414-013-0962-0. Epub 2014 Jan 18. Int J Legal Med. 2014. PMID: 24442913
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases